TREATMENT WITH EVEROLIMUS LEADS TO CMV-PROTECTION DUE TO INCREASED POTENCY OF CMV-SPECIFIC CD4+T CELLS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS COMPARED TO A STANDARD REGIMEN: 12 MONTHS DATA OF THE ATHENA STUDY
TRANSPLANT INTERNATIONAL(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要